Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

How to Find Strong Buy Aerospace Stocks Using the Zacks Rank
How to Find Strong Buy Aerospace Stocks Using the Zacks Rank

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor.

But what's the best way to find the right combination

How to Find Strong Buy Oils and Energy Stocks Using the Zacks Rank
How to Find Strong Buy Oils and Energy Stocks Using the Zacks Rank

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor.

But what's the best way to find the right combination

How to Boost Your Portfolio with Top Aerospace Stocks Set to Beat Earnings
How to Boost Your Portfolio with Top Aerospace Stocks Set to Beat Earnings

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

3 Thematic ETFs Making New Highs Ahead of the Market
3 Thematic ETFs Making New Highs Ahead of the Market

Markets have been uneven to start 2026. Major indexes have struggled to make sustained progress, former technology leaders have traded lower, stress in areas such as private credit has added to the

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease

Rocket Pharmaceuticals RCKT announced that the FDA has granted accelerated approval to its gene therapy Kresladi (marnetegragene autotemcel) to treat patients with severe leukocyte adhesion

ChoiceOne Financial Services (COFS) Upgraded to Buy: What Does It Mean for the Stock?
ChoiceOne Financial Services (COFS) Upgraded to Buy: What Does It Mean for the Stock?

ChoiceOne Financial Services, Inc. (COFS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful

PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on PAVmed Inc. (PAVM), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock

Why KLA (KLAC) Could Beat Earnings Estimates Again
Why KLA (KLAC) Could Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? KLA (KLAC), which belongs to the Zacks

Sera Prognostics (SERA) Upgraded to Buy: What Does It Mean for the Stock?
Sera Prognostics (SERA) Upgraded to Buy: What Does It Mean for the Stock?

Sera Prognostics, Inc. (SERA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

Invesco Mortgage Capital (IVR) Upgraded to Buy: Here's What You Should Know
Invesco Mortgage Capital (IVR) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Invesco Mortgage Capital (IVR), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

Johnson Outdoor (JOUT) Upgraded to Strong Buy: Here's Why
Johnson Outdoor (JOUT) Upgraded to Strong Buy: Here's Why

Investors might want to bet on Johnson Outdoor (JOUT), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces

Futu Holdings (FUTU) Upgraded to Strong Buy: What Does It Mean for the Stock?
Futu Holdings (FUTU) Upgraded to Strong Buy: What Does It Mean for the Stock?

Futu Holdings Limited Sponsored ADR (FUTU) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward

Month of March Goes Out Like a Bull
Month of March Goes Out Like a Bull

Tuesday, March 31st, 2026It’s the final trading day of a dismal month of March and Q1 overall — it was shaping up to be the worst trading month in four years, but it fought back valiantly today. The

AU Trades at a Discount to Industry: Right Time to Buy the Stock?
AU Trades at a Discount to Industry: Right Time to Buy the Stock?

AngloGold Ashanti PLC AU stock is currently trading at a forward 12-month earnings multiple of 10.55X, which is a discount to the Zacks Mining – Gold industry’s average of 10.97X.

 

Image Source:

Earnings Preview: Constellation Brands (STZ) Q4 Earnings Expected to Decline
Earnings Preview: Constellation Brands (STZ) Q4 Earnings Expected to Decline

The market expects Constellation Brands (STZ) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended February 2026. This widely-known

Why Is Helios Technologies (HLIO) Down 8.9% Since Last Earnings Report?
Why Is Helios Technologies (HLIO) Down 8.9% Since Last Earnings Report?

It has been about a month since the last earnings report for Helios Technologies (HLIO). Shares have lost about 8.9% in that time frame, underperforming the S&P 500.

Will the recent negative trend

Why Bank of America (BAC) is Poised to Beat Earnings Estimates Again
Why Bank of America (BAC) is Poised to Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Bank of America (BAC), which belongs to

This New Spinoff Is a Nuclear and AI Chip Beneficiary Worth Watching
This New Spinoff Is a Nuclear and AI Chip Beneficiary Worth Watching

Solstice Advanced Materials (NASDAQ: SOLS) is a relatively new stock to the market, but one that has gotten off to a blistering start. At the end of October 2025, the over $100 billion

Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline
Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline

The market expects Neogen (NEOG) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended February 2026. This widely-known consensus outlook is